Clinical Trials Logo

Parenteral Nutrition clinical trials

View clinical trials related to Parenteral Nutrition.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06234163 Completed - Enteral Nutrition Clinical Trials

The Effect of Enteral and Parenteral Nutrition Training

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Malnutrition is considered as a deficiency of energy, protein or other nutrients. Malnutrition is a big problem for surgical patients. Various physiological problems may occur in patients with inadequate or malnutrition, such as prolonged wound healing time, decreased muscle strength and deterioration in immune system functions. It is recommended to start oral nutrition in the early postoperative period. In cases where the oral route is not preferred, enteral and parenteral nutritional support should be provided to the patient continuously or intermittently. Failure to identify individuals at risk of malnutrition means delaying the nutritional support the patient needs. Close observations and evaluations made by nurses during the day can ensure early diagnosis of the patient at risk of malnutrition and receive the necessary nutritional support. In order for nurses to fulfill their duties regarding nutritional care, they must have sufficient knowledge and skills on the subject and perceive the importance of nutritional care for patients. "Care" forms the basis of nursing. The interaction between patient and nurse affects the process and quality of care. Care behaviors include some basic skills such as listening carefully to the patient by making eye contact, empathy, demonsrating professional knowledge and skills, taking responsibility for the patient, and being accessible. In order to increase the quality of nursing care given to patients, it is necessary to provide evidence-based care and ensure that the care given is compatible with the values and expectations of the patients. For these reasons, this study aimed to examine the effect of enteral and parenteral nutrition (EPN) training on the knowledge level and care behaviors of surgical nurses regarding nutritional care.

NCT ID: NCT05519787 Completed - Chemotherapy Clinical Trials

A Retrospective, Observational, Monocenter, Study to Describe the Utilization and Overall Safety and Performance of POLYSITE®/SEESITE® Implantable Ports

Start date: December 14, 2021
Phase:
Study type: Observational

This study is a retrospective, observational, monocenter case series. The purpose of this study is to collect clinical data to describe the use of POLYSITE® and SEESITE® devices and verify overall safety and performance. This study is part of the Post-Market Clinical Follow-up (PMCF) activities of the PEROUSE MEDICAL manufacturer. The primary data source for this study was patient's medical records from a French Hospital. The study population was defined as all patients who did receive POLYSITE® and SEESITE®. Data from a minimum of 50 patients were planned for the statistical review.

NCT ID: NCT05337228 Completed - Clinical trials for Parenteral Nutrition

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301

Start date: August 9, 2022
Phase: Phase 3
Study type: Interventional

This study is designed to evaluate the safety and efficacy of IN-C006 Peri inj. and RPN301 in postoperative patients requiring central parenteral nutrition.

NCT ID: NCT05299099 Completed - Clinical trials for Parenteral Nutrition

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301

Start date: May 4, 2022
Phase: Phase 3
Study type: Interventional

This study is designed to evaluate the safety and efficacy of IN-C006 inj. and RCN301 in postoperative patients requiring central parenteral nutrition.

NCT ID: NCT04816734 Completed - Clinical trials for Parenteral Nutrition

Initial Parenteral Nutrition Education of Parent Assessment Plan

DISEPEIN
Start date: March 25, 2021
Phase: N/A
Study type: Interventional

The department of gastroenterology, hepatology and pediatric nutrition at the Necker-Enfants Malades hospital has created an evaluation system for the initial therapeutic education program followed by parents of children requiring parenteral nutrition at the Necker-Enfants Malades hospital. The aim of the study is to test this evaluation plan and assess its interest in the learning process of parents and then include it in the initial therapeutic education program for parents of children requiring parenteral nutrition of Necker-Enfants Malades hospital.

NCT ID: NCT04234490 Completed - Clinical trials for Parenteral Nutrition

Longitudinal Evaluation of the Impact of Parenteral Nutrition

Start date: March 2, 2020
Phase:
Study type: Observational

Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients. The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN. This study will recruit HPN patients across the United Kingdom (UK) and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers.

NCT ID: NCT04234152 Completed - Lung Diseases Clinical Trials

Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study

C-SMART-PN
Start date: November 23, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine if a new and simple method involving complete photo-protection of multivitamins only (since sampling through infusion) will result in a significant reduction of peroxide contamination of parenteral nutrition compared to standard method of parenteral nutrition preparation and infusion in extremely preterm infants.

NCT ID: NCT04006730 Completed - Clinical trials for Parenteral Nutrition

Analysis of the Pharmaceutical Validation of Picc Line Installation Requests at the Nîmes University Hospital

PICCLINIC
Start date: October 1, 2018
Phase:
Study type: Observational

The picc line is a central venous catheter inserted peripherally into a deep vein in the arm (cephalic, basilic or axillary) whose distal end is located at the junction of the superior vena cava / atrium. It is installed for a minimum of 7 days (1), and can be stored for up to 6 months or more if it is functional. For treatments with an indication of more than 3 months, it is common practice to place an implantable catheter chamber. The main indications for picc line placement are: long-term antibiotic therapy, parenteral nutrition, chemotherapy or long-term venous approach when difficulties are encountered in applying a peripheral venous route to the patient. Quickly adopted by medical teams, picc lines are not without risk, however, and three complications are mainly reported: catheter obstruction, deep vein thrombosis and infections. In order to avoid any risk of unnecessary complications, it therefore seems appropriate to target the most appropriate device upstream of the procedure according to the provisional indication. An inventory of pharmaceutical interventions carried out during picc line requests would make it possible to lay the foundations for considering actions to be implemented with the various services requesting picc line and proposals for improvement for the follow-up of patients with picc line to reduce the risk of complications.

NCT ID: NCT03792100 Completed - Surgery Clinical Trials

Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition

Start date: January 3, 2019
Phase: Phase 3
Study type: Interventional

The present protocol describes a randomized, patient-blinded study in which either SmofKabiven emulsion for infusion or a hospital compounded "All in one" control Total Parenteral Nutrition (TPN) regimen will be given to adult surgical patients for 5 consecutive days. As serum prealbumin is a well-established surrogate efficacy parameter reflecting the patient´s nutritional status, the change of the serum prealbumin level at the day of the final study visit compared to baseline will represent the primary efficacy parameter in the present study.

NCT ID: NCT03284398 Completed - Clinical trials for Parenteral Nutrition

Three-Chamber Bags Retrospective Study in Spain

Start date: December 14, 2017
Phase:
Study type: Observational

The primary study objective is to assess the rates of blood stream infection (BSI) from the use of Three-Chamber Bags (e.g., SmofKabiven®, Kabiven®, others) compared to Hospital Compounded Bags (HCBs) in patients requiring parenteral nutrition in Spanish hospitals.